Date | Analyst | Company | Last | Target | Call | Valuation |
07/15/21 | CIMB | Parkway Life | 4.77 | 5.05 | Add | DDM |
07/15/21 | DBS Vickers | Parkway Life | 4.77 | 5.75 | Buy | DCF |
07/15/21 | UOB Kay Hian | Parkway Life | 4.77 | 4.72 | Hold | |
07/27/21 | Lim & Tan | Parkway Life | 4.72 | 0 | Hold | |
11/05/21 | CIMB | Parkway Life | 4.65 | 5.05 | Add | DDM |
12/13/21 | Lim & Tan | Parkway Life | 5.07 | 0 | Hold | |
01/25/22 | Lim & Tan | Parkway Life | 4.94 | 4.97 | Hold | |
02/11/22 | UOB Kay Hian | Parkway Life | 4.62 | 4.72 | Hold | |
03/04/22 | DBS Vickers | Parkway Life | 4.62 | 5.75 | Buy | DCF |
04/13/22 | UOB Kay Hian | Parkway Life | 4.81 | 4.82 | Hold | DDM |
04/26/22 | CIMB | Parkway Life | 4.96 | 5.05 | Hold | |
04/26/22 | UOB Kay Hian | Parkway Life | 4.96 | 5.42 | Hold | DDM |
06/10/22 | SAC Capital | Parkway Life | 4.93 | 4.69 | Hold | |
06/10/22 | DBS Vickers | Parkway Life | 4.93 | 5.5 | Buy | DCF |
08/10/22 | Lim & Tan | Parkway Life | 4.8 | 5.08 | Hold | |
09/14/22 | CIMB | Parkway Life | 4.75 | 5.06 | Hold | |
09/14/22 | Citi Research | Parkway Life | 4.75 | 5.02 | Hold | |
09/16/22 | UOB Kay Hian | Parkway Life | 4.67 | 4.65 | Hold | |
09/21/22 | DBS Vickers | Parkway Life | 4.62 | 5.5 | Buy | DCF |
09/21/22 | Lim & Tan | Parkway Life | 4.62 | 5 | Hold | |
10/21/22 | UOB Kay Hian | Parkway Life | 3.81 | 4.13 | Hold | DDM |
11/02/22 | Lim & Tan | Parkway Life | 3.97 | 4.7 | Hold |
Friday, November 4, 2022
Parkway Life - Stock calls
Stock calls for 3 November 2022
Date | Analyst | Company | Last | Target | Call | Valuation |
11/03/22 | DBS Vickers | Capitaland Investment | 3.08 | 4.3 | Buy | |
11/03/22 | DBS Vickers | Comfortdelgro | 1.32 | 1.95 | Buy | |
11/03/22 | CIMB | DBS | 33.66 | 40.2 | Add | GGM |
11/03/22 | Lim & Tan | DBS | 33.66 | 40 | Accumulate | |
11/03/22 | DBS Vickers | Hour Glass | 1.97 | 2.12 | Hold | PER9x FY23/24 |
11/03/22 | UOB Kay Hian | Keppel Pacific | 0.57 | 0.74 | Buy | |
11/03/22 | UOB Kay Hian | Manulife US Reit | 0.355 | 0.63 | Buy | DDM |
11/03/22 | DBS Vickers | Manulife US Reit | 0.355 | 0.48 | Buy | |
11/03/22 | DMG & Partners | Manulife US Reit | 0.355 | 0.64 | Buy | DDM |
11/03/22 | CIMB | Manulife US Reit | 0.355 | 0.69 | Add | |
11/03/22 | DBS Vickers | Nanofilm | 1.79 | 2.54 | Buy | PER20x FY23 |
11/03/22 | Citi Research | Nanofilm | 1.79 | 1.55 | Sell | PER14x FY23 |
11/03/22 | Lim & Tan | Nanofilm | 1.79 | 2.72 | Sell | |
11/03/22 | Citi Research | Netlink | 0.865 | 0.95 | Buy | |
11/03/22 | DBS Vickers | Netlink | 0.865 | 0.9 | Hold | |
11/03/22 | OCBC | Raffles Medical | 1.33 | 1.5 | Buy | |
11/03/22 | Kim Eng | Raffles Medical | 1.33 | 1.6 | Buy | |
11/03/22 | UOB Kay Hian | SIA Engineering | 2.17 | 2.6 | Buy | DCF |
11/03/22 | DBS Vickers | SIA Engineering | 2.17 | 2.8 | Buy | |
11/03/22 | Lim & Tan | Singapore Medical | 0.38 | 0.43 | Accept offer | Revised offer $0.40 |
Thursday, November 3, 2022
Pan-United - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
08/10/21 | phillip | PanUnited | 0.33 | 0.44 | Buy | EV/Ebitda7.8x FY21 |
01/06/22 | Lim & Tan | PanUnited | 0.335 | 0.5 | Buy | |
03/14/22 | Lim & Tan | PanUnited | 0.35 | 0 | Buy | |
03/14/22 | phillip | PanUnited | 0.35 | 0.46 | Buy | PER16x FY22 |
03/21/22 | Lim & Tan | PanUnited | 0.35 | 0.54 | Buy | EV/Ebitda5.6x |
03/30/22 | CIMB | PanUnited | 0.385 | 0.53 | Add | PER12.3x |
03/30/22 | SAC Capital | PanUnited | 0.385 | 0.56 | Buy | EV/Ebitda6.6x FY23 |
04/07/22 | CIMB | PanUnited | 0.41 | 0.56 | Add | |
05/05/22 | CIMB | PanUnited | 0.4 | 0.56 | Add | |
06/13/22 | phillip | PanUnited | 0.43 | 0.68 | Buy | PER12x FY22 |
06/13/22 | SAC Capital | PanUnited | 0.43 | 0.53 | Buy | |
07/15/21 | Lim & Tan | PanUnited | 0.465 | 0.68 | Accumulate | |
08/05/22 | CIMB | PanUnited | 0.45 | 0.57 | Add | |
08/11/22 | SAC Capital | PanUnited | 0.445 | 0.53 | Buy | |
08/12/22 | phillip | PanUnited | 0.45 | 0.54 | Buy | PER12x FY22 |
08/22/22 | Lim & Tan | PanUnited | 0.44 | 0.54 | Buy | |
09/22/22 | CIMB | PanUnited | 0.43 | 0.57 | Add | |
09/23/22 | Lim & Tan | PanUnited | 0.43 | 0.54 | Buy | EV/Ebitda6.9x |